Hypoxia inducible factor-1α (HIF-1α) in breast cancer: The crosstalk with oncogenic and onco-suppressor factors in regulation of cancer hallmarks
Pathology - Research and Practice · 2023
DOI: 10.1016/j.prp.2023.154676 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2023. Verfasst von Sepideh Mirzaei und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Faculty of Science, Islamic Azad University, Science and Research Branch, Tehran, Iran. Electronic address: sepidehmirzaei.smv…. Hauptthemen laut MEDLINE: Hypoxia-Inducible Factor 1, alpha Subunit, Breast Neoplasms. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 262 Literaturangaben.
Abstract (Originalsprache)
Low oxygen level at tumor microenvironment leads to a condition, known as hypoxia that is implicated in cancer progression. Upon hypoxia, HIF-1α undergoes activation and due to its oncogenic function and interaction with other molecular pathways, promotes tumor progression. The HIF-1α role in regulating breast cancer progression is described, Overall, HIF-1α has upregulation in breast tumor and due to its tumor-promoting function, its upregulation is in favor of breast tumor progression. HIF-1α overexpression prevents apoptosis in breast tumor and it promotes cell cycle progression. Silencing HIF-1α triggers cycle arrest and decreases growth. Migration of breast tumor enhances by HIF-1α signaling and it mainly induces EMT in providing metastasis. HIF-1α upregulation stimulates drug resistance and radio-resistance in breast tumor. Furthermore, HIF-1α signaling induces immune evasion of breast cancer. Berberine and pharmacological intervention suppress HIF-1α signaling in breast tumor and regulation of HIF-1α by non-coding RNAs occurs. Furthermore, HIF-1α is a biomarker in clinic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, Faculty of Science, Islamic Azad University, Science and Research Branch, Tehran, Iran. Electronic address: sepidehmirzaei.smv@gmail.com.
- Department of Biophysics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran 14117-13116, Iran.
- Department of Biology, Central Tehran Branch, Islamic Azad University, Tehran, Iran.
- Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115, USA.
Zitieren
APA
Mirzaei, S., Ranjbar, B., Tackallou, S. H., & Aref, A. R. (2023). Hypoxia inducible factor-1α (HIF-1α) in breast cancer: The crosstalk with oncogenic and onco-suppressor factors in regulation of cancer hallmarks. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2023.154676
Vancouver
Mirzaei S, Ranjbar B, Tackallou SH, Aref AR. Hypoxia inducible factor-1α (HIF-1α) in breast cancer: The crosstalk with oncogenic and onco-suppressor factors in regulation of cancer hallmarks. Pathology - Research and Practice. 2023. doi:10.1016/j.prp.2023.154676
BibTeX
@article{Mirzaei2023,
author = {Mirzaei, Sepideh and Ranjbar, Bijan and Tackallou, Saeed Hesami and Aref, Amir Reza},
title = {Hypoxia inducible factor-1α (HIF-1α) in breast cancer: The crosstalk with oncogenic and onco-suppressor factors in regulation of cancer hallmarks},
journal = {Pathology - Research and Practice},
year = {2023},
doi = {10.1016/j.prp.2023.154676}
}
EUVIMED